Outcomes for long-term GH replacement safety in adolescent and adult patients with GHD confirmed a favorable safety profile of GH, despite the evidence of a link between the GH/IGF-I axis and cancer risk supported by some epidemiological and experimental studies. Here, GH1 is linked to cancer.